Loading...
Loading...
PDI, Inc.
PDII today
announced the signing of a three-year agreement with a current Top 5 global
pharmaceutical client and renewal of a one-year engagement with a specialty
pharmaceutical client. Approximately $48 million in revenue is expected to be
generated in 2012 between both contracts.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in